Investors seemed to panic after the announcement, with a sell-off driving Keros' share price down 73%, reversing strong gains ...

Sports marketing offers healthcare brands an alternative channel to reach their audiences and align with the strong brand ...

While 2025 remains an unknown quantity, it’s clear that fundraisers and investors see the value in visiting London in ...

The purchase price of the facility was not disclosed, but Lilly says its new $3 billion investment – part of $23 billion ...

The Institute for Clinical and Economic Review (ICER) has published its annual report on "unsupported" price increases for medicines that it says have added around $815 million to US drug spending.

Agamree was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in January and has a pre-discount list ...

Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker ...

Read Deep Dive: AI 2024 in full pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, ...

A new study has confirmed that the rate of colorectal cancer is rising in younger adults around the world, with England among ...

Mulvany – who left BenevolentAI when it listed on the Amsterdam stock exchange in 2022 and retains a sizeable stake in the ...

As a result of the preliminary STOMP data – which gave the chances of a positive outcome from the study at less than 1% – the ...

The BBC's probe into Diary of a CEO has followed an increase in emphasis on health topics by Bartlett that, according to the broadcaster, has resulted in a big increase in viewers and subscribers for ...